Key result
Patients with Ewing's sarcoma relapsing after therapy discontinuation had a high probability of attaining a second remission and surviving their disease.
Cohort
Patients with Ewing's sarcoma who relapse after completing therapy have a high probability of attaining a second remission and surviving their disease.
Answers are grounded in this paper and cite their sources.
May inform salvage approaches in relapsed Ewing sarcoma; hypothesis-generating and requires prospective validation.
While the proportion of patients with Ewing's sarcoma attaining and maintaining long-term remission has markedly improved, a proportion of patients suffer relapse of the tumor. In our experience relapses may occur late in the course of the disease, approximately 20% of those at risk beyond 5 years having recurrence of tumor. Review of our data indicates that for patients relapsing after therapy has been discontinued, the probability of attaining second remission is high (0.84) and that a significant proportion of these patients attaining second complete remission will survive their disease (0.60).
No takes yet. Share an insight, caveat, or question.
Hayes et al. (1987) conducted a cohort in Ewing's sarcoma. Relapse after completing therapy was evaluated on Attaining second remission. Patients with Ewing's sarcoma relapsing after therapy discontinuation had a high probability of attaining a second remission and surviving their disease.
Synapse has enriched 10 related papers. Consider them for comparative context: